1014 related articles for article (PubMed ID: 21487341)
41. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
[TBL] [Abstract][Full Text] [Related]
42. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
[TBL] [Abstract][Full Text] [Related]
43. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL
Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
[TBL] [Abstract][Full Text] [Related]
44. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema.
Chun DW; Heier JS; Topping TM; Duker JS; Bankert JM
Ophthalmology; 2006 Oct; 113(10):1706-12. PubMed ID: 17011952
[TBL] [Abstract][Full Text] [Related]
45. Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema.
Blumenkranz MS; Haller JA; Kuppermann BD; Williams GA; Ip M; Davis M; Weinberg DV; Chou C; Whitcup SM
Retina; 2010; 30(7):1090-4. PubMed ID: 20616686
[TBL] [Abstract][Full Text] [Related]
46. A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema.
Dugel PU; Blumenkranz MS; Haller JA; Williams GA; Solley WA; Kleinman DM; Naor J
Ophthalmology; 2012 Jan; 119(1):124-31. PubMed ID: 22115710
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
Guigou S; Pommier S; Meyer F; Hajjar C; Merite PY; Parrat E; Rouhette H; Rebollo O; Matonti F
Ophthalmologica; 2015; 233(3-4):169-75. PubMed ID: 25924737
[TBL] [Abstract][Full Text] [Related]
48. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
49. Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema.
Dutra Medeiros M; Postorino M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
Ophthalmologica; 2014; 231(3):141-6. PubMed ID: 24356099
[TBL] [Abstract][Full Text] [Related]
50. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.
Pichi F; Specchia C; Vitale L; Lembo A; Morara M; Veronese C; Ciardella AP; Nucci P
Am J Ophthalmol; 2014 Mar; 157(3):607-15.e1. PubMed ID: 24528934
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
[TBL] [Abstract][Full Text] [Related]
52. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Er H; Yilmaz H
Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
[TBL] [Abstract][Full Text] [Related]
53. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).
Capone A; Singer MA; Dodwell DG; Dreyer RF; Oh KT; Roth DB; Walt JG; Scott LC; Hollander DA
Retina; 2014 Feb; 34(2):342-51. PubMed ID: 23846381
[TBL] [Abstract][Full Text] [Related]
55. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
Ozsaygili C; Duru N
Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
[TBL] [Abstract][Full Text] [Related]
56. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study.
Bellocq D; Korobelnik JF; Burillon C; Voirin N; Dot C; Souied E; Conrath J; Milazzo S; Massin P; Baillif S; Kodjikian L
Br J Ophthalmol; 2015 Jul; 99(7):979-83. PubMed ID: 25583283
[TBL] [Abstract][Full Text] [Related]
58. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
Gibran SK; Khan K; Jungkim S; Cleary PE
Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
[TBL] [Abstract][Full Text] [Related]
59. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Veritti D; Lanzetta P; Perissin L; Bandello F
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
[TBL] [Abstract][Full Text] [Related]
60. Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes.
Khurana RN; Palmer JD; Porco TC; Wieland MR
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):56-61. PubMed ID: 25559510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
